Abstract

BackgroundPrognostic markers for meningioma recurrence are needed to guide patient management. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before.MethodsWe retrospectively searched our database for patients with meningioma WHO grade I and complete resection provided between 2002 and 2016. Demographical, clinical, pathological, and outcome data were recorded. The following covariates were included in the statistical model: age, sex, clinical history of unrelated tumor disease, and localization (skull base vs. convexity). Particular interest was paid to the patients’ past medical history. The study endpoint was date of tumor recurrence on imaging. Prognostic factors were obtained from multivariate proportional hazards models.ResultsOut of 976 meningioma patients diagnosed with a meningioma WHO grade I, 416 patients fulfilled our inclusion criteria. We encountered 305 women and 111 men with a median age of 57 years (range: 21–89 years). Forty-six patients suffered from a tumor other than meningioma, and no TERT mutation was detected in these patients. There were no differences between patients with and without a positive oncological history in terms of age, tumor localization, or mitotic cell count. Clinical history of prior tumors other than meningioma showed the strongest association with meningioma recurrence (p = 0.004, HR = 3.113, CI = 1.431–6.771) both on uni- and multivariate analysis.ConclusionPast medical history of tumors other than meningioma might be associated with an increased risk of meningioma recurrence. A detailed pre-surgical history might help to identify patients at risk for early recurrence.

Highlights

  • Meningiomas are the most common primary intracranial tumors in adults

  • Forty-six patients suffered from a tumor other than meningioma, and no TERT mutation was detected in these patients

  • Past medical history of tumors other than meningioma might be associated with an increased risk of meningioma recurrence

Read more

Summary

Introduction

Meningiomas are the most common primary intracranial tumors in adults. Annual incidence rate is estimated at 7.9 cases per 100,000 persons, and prevalence appears to rise with age [17]. The overwhelming majority of meningiomas are considered to be sporadic. Factors such as past medical history of tumors other than meningioma (including glioma, acute lymphocytic leukemia, prostate cancer, papillary carcinoma of the thyroid, uterus myomas, and endometriosis) but. Within vestibular schwannomas, a shortened time to progression was observed within patients harboring an unrelated tumor disease [27]. Taken together, these findings already point to possible systemic genetic and molecular factors that play a putative role in the development of meningiomas and in their recurrent growths. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call